Nigeria’s House of Representatives has initiated a comprehensive investigation into the management of over $4.6 billion in health grants received from international partners between 2021 and 2025. The colossal sum, comprising $2.8 billion from the Global Fund and $1.8 billion from the US Agency for International Development (USAID), was designated for the critical fight against HIV/AIDS, Tuberculosis (TB), Malaria, and for strengthening the national health system. The inquiry, led by the newly renamed House Committee on Infectious Diseases, was launched following persistent concerns that, despite the massive foreign investment, the diseases continue to heavily burden the country.
Rt. Hon. Amobi Godwin Ogah, the Committee Chairman, expressed strong dissatisfaction, lamenting that Nigeria “continues to reel under the heavy burden” of these diseases and that the relief citizens expect “remains elusive.” He emphasised that the probe is essential to ensure transparency in the use of aid, pointing out that nearly 90% of Nigeria’s intervention funding for these diseases comes from foreign partners. “Any form of grant or assistance that excludes Nigeria from managing its implementation is unacceptable,” Ogah declared, stressing that the era of Nigeria being a “passive observer” in managing donor funds is over. He directed the Federal Ministry of Health and the Country Coordinating Mechanism (CCM) to ensure all principal recipients and implementing partners present their operational plans to the National Assembly for vetting before funds are released, warning that the days of expending resources without legislative approval are gone.
The lack of demonstrable impact from the grants is not just a public health failure; it represents a significant drag on Nigeria’s economic prospects. Uncontrolled infectious diseases such as HIV, TB, and Malaria severely erode human capital, which is the single most valuable resource for any developing economy. High disease burdens cause increased absenteeism, reduced efficiency, and premature deaths, all of which directly lower national output and Gross Domestic Product (GDP). The cost of treating these widespread infections is enormous, and when foreign aid is misused, the gap must often be filled by the government or by households, pushing more people into poverty. Furthermore, mismanagement and corruption within the health sector deter international trust and investment. The Minister’s warning that terror financing has been linked to the diversion of grant funds adds a serious national security and financial risk dimension, which can further destabilise the economy and scare away legitimate foreign direct investment. By ensuring these billions are spent effectively, Nigeria stands to unlock substantial economic gains, making the investigation crucial for both public well-being and fiscal responsibility.
To strengthen the country’s long-term health governance, Ogah revealed a plan to rebrand the National Agency for the Control of AIDS (NACA) into the National Agency for the Control of AIDS, Tuberculosis and Malaria (NACATAM). This move is designed to create a single, multi-sectoral body for integrated disease control, helping to reduce fragmentation and waste, and ultimately reducing Nigeria’s heavy dependence on external resources. The Committee announced it would collaborate with anti-graft agencies like the EFCC and ICPC to trace the financial flow of the donor funds, ensuring accountability for all expenditures. The Minister of Health and Social Welfare, Dr. Muhammad Ali Pate, voiced his support for the parliamentary scrutiny, noting it was a timely step towards greater accountability and national ownership. “After more than two decades of donor support, Nigeria must begin to take charge of financing its health priorities,” Dr. Pate remarked, believing transparency will encourage both trust and local investment. The Speaker of the House, represented by Hon. Ibrahim Isiaka, reaffirmed the House’s commitment to openness, stating the investigation is a “democratic process aimed at ensuring transparency and value for every naira and dollar invested” and will help Nigeria meet its goal of eradicating infectious diseases by 2030.
